The International Symposium for Tissue Phenomics
EVENT DATE: Oct 17 - Oct 18, 2014
EVENT HOST: Definiens
EVENT LOCATION: San Francisco, California
EVENT WEB LINK: Event URL Coming Soon
EVENT AGENDA: Download
At the 2014 International Symposium for Tissue Phenomics™, attendees enjoyed expert presentations on immuno-oncology and big data, valuable panel discussions, and excellent networking with peers and other industry experts.
- Keynote addresses by Nobel Laureate Dr. Gerd Binnig and Dr. Carlo Bifulco
- Thought-leading presentations by industry experts
- Extensive networking with peers and experts in cancer diagnostics and Tissue Phenomics
Tissue Phenomics experts and key opinion leaders shared their insights on:
- Turning tissue images into big data for robust correlation to clinical outcomes.
- How immuno-oncology is accelerating by using quantitative spatial analysis of the tumor microenvironment.
- Using Tissue Phenomics to find new markers for stratifying patient populations.
Prognostic and Predictive Significance of the Immunological Tumor Environment
COIN-ing Potential Clinically Translatable Markers in Metastatic Colorectal Cancer Through Tissue Phenomics
Improving Therapy-Relevant Breast Cancer Protein Profiling Using Quantitative Immunofluorescence
Novel Patient Stratification and Predictive Imaging Biomarkers for Development of Oncology Therapies
Use of Computer Tumor Tissue Imaging Algorithms to Assess the Role of Microenvironment in Melanoma Brain Metastases
Tissue Phenomics: From Biomarker Discovery to Clinical Diagnostic Assay Commercialization
Tissue Quality and Clinical Data: The Bottleneck for Drug and Biomarker Development
Measurement of Target Engagement and Pharmacodynamic Response to Investigational Anti-Cancer Agents in Phase 1 Clinical Trials
Development of an Encapsulated Cell Replacement Therapy for Diabetes
Immunoscore / Immunoprofile: Assessing Anti-Cancer Immunity as a Biomarker to Stratify Patients for Clinical Trials
Implementation of Image Analysis for Biomarker Assessment of Pre-Clinical Tumor Models and Clinical Patient Samples
Companion Diagnostics: Aligning Development, Commercialization, and Market Access